January 19, 2021

SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi)

IndiaProduction

IndiaProduction

Recommended Reports

5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

5-Hydroxytryptamine Receptor 6 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Pharmaceuticals Industry Deals and Trends in July 2019 - Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)

View All

More

Medical Technology UK 2023

International congress on pediatrics neonatal and nursing care, Prague

Outsourcing in Clinical Trials: Medical Devices USA 2023

Outsourcing in Clinical Trials West Coast (& device stream) 2023